ArticleWorld journal of diabetes2020
Access to insulin delivery devices and glycated haemoglobin in lower-income countries.
Article in World journal of diabetes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Comparison of diagnostic accuracy for diabetes diagnosis: A systematic review and network meta-analysis.Frontiers in medicine · 2023Pooled it
- Effects of a 50% versus 100% pre-prandial insulin bolus reduction to improve glycemic safety during postprandial continuous and intermittent exercise in adults with type 1 diabetes treated with multiple daily injections.Frontiers in endocrinology · 2026Trial
- Individual and community-level factors affecting diabetes screening uptake among adults in 14 low- and middle-income countries: a multilevel mixed-effects analysis of recent demographic and health surveys.BMC public health · 2026Article
- Review
- Economic evaluation of insulin glargine compared with human insulin for youth with type 1 diabetes in Tanzania and Bangladesh.PloS one · 2026Article
- Pediatric Type 1 Diabetes Care in Indonesia: A Review of Current Challenges and PracticeJournal of clinical research in pediatric endocrinology · 2025Review
- Insulin-Related Consumables Should not be Ignored While Pooling Insulin Purchases: Experience From China.Health care science · 2025Article
- Challenges in implementing Indonesia's community-based chronic disease management program (Prolanis): A scoping review.AIMS public health · 2025Review
- Affordable oral proinsulin bioencapsulated in plant cells regulates blood sugar levels similar to natural insulin.Biomaterials · 2023Article
- Time to first optimal glycemic control and its predictors among type 1 diabetic children in Bahir Dar city public referral hospitals, North West Ethiopia: a retrospective follow up study.BMC pediatrics · 2022Article
- Article
- HbA1c performs well in monitoring glucose control even in populations with high prevalence of medical conditions that may alter its reliability: the OPTIMAL observational multicenter study.BMJ open diabetes research & care · 2021Observational
- A global perspective on the issue of access to insulin.Diabetologia · 2021Review
- Diagnostics and monitoring tools for noncommunicable diseases: a missing component in the global response.Globalization and health · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundYoung people with type 1 diabetes in low-and-middle income countries face many challenges in accessing care, with various essential supplies needed for survival and long-term health.
aimTo study insulin delivery devices and glycated haemoglobin (HbA1c) testing.
methodsA survey was conducted in 2019 of leading diabetes centres in 41 countries supported by the Life for a Child Program. The survey covered numerous aspects concerning availability and costs at all levels of the health system, local usage patterns and attitudes, obstacles, and other aspects.
resultsThirty-seven countries returned the survey (90.2% response rate). Key findings included: Syringe use was most common (83.1%), followed by insulin pens (16.7%) and pumps (0.2%). 48.6% of public health systems did not provide syringes, even with a co-payment. Use of suboptimal syringe/needle combinations was common. Needles were generally reused in almost all countries (94.3%,
conclusionLarge gaps exist for adequate access to appropriate insulin delivery devices and HbA1c testing. Public health systems in low-and-middle income countries should increase affordable provision. There are also needs for specific health professional training and diabetes education; elimination of customs duties and taxes; development of inexpensive, robust HbA1c testing methods that do not require refrigeration of testing supplies; differential pricing schemes; and other solutions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.